ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Donald Ross
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Athanasiou, T.
Right arrow Articles by Ross, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Athanasiou, T.
Right arrow Articles by Ross, D.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2004;78:1489-1495
© 2004 The Society of Thoracic Surgeons

Review

The Ross II Procedure: Pulmonary Autograft in the Mitral Position

Thanos Athanasiou, MD, PhDa,*, Ashok Cherian, MDa, Donald Ross, FRCS

a Department of Robotic and Minimally Invasive Cardiothoracic Surgery, St. Mary's Hospital, London, United Kingdom

* Address reprint requests to Dr Athanasiou, Robotic and Minimally Invasive Cardiothoracic Surgery, St. Mary's Hospital, 70 St. Olaf's Rd, Fulham, London SW6 7DN, UK
tathan5253{at}aol.com

The surgical management of mitral valve disease in women of childbearing age, young patients, and children with congenital mitral valve defects is made difficult by the prospect of lifelong anticoagulation. We suggest the use of a pulmonary autograft in the mitral position (Ross II procedure) as an alternative surgical technique. We present a review of the literature, historical perspectives, indications, selection criteria, and surgical technique for the Ross II procedure. Our literature search identified 14 studies that reported results from the Ross II operation. Performed in 103 patients, the overall in-hospital mortality was 7 (6.7%), with a late mortality of 10 (9%). Although further research is needed, current evidence suggests the Ross II operation is a valuable alternative in low-risk young patients where valve durability and the complication rate from other procedures is unsatisfactory and anticoagulation not ideal.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. S. Kumar, S. Talwar, and A. Gupta
Mitral valve replacement with the pulmonary autograft: midterm results.
J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 359 - 364.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
T. Gudbjartsson, T. Absi, and S. Aranki
Mitral Valve Replacement
Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068.
[Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Kabbani, H. Jamil, F. Nabhani, A. Hamoud, K. Katan, N. Sabbagh, A. Koudsi, L. Kabbani, and G. Hamed
Analysis of 92 mitral pulmonary autograft replacement (Ross II) operations.
J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 902 - 908.e7.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.